• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

家族性囊性甲状旁腺腺瘤病

Familial cystic parathyroid adenomatosis.

作者信息

Mallette L E, Malini S, Rappaport M P, Kirkland J L

出版信息

Ann Intern Med. 1987 Jul;107(1):54-60. doi: 10.7326/0003-4819-107-1-54.

DOI:10.7326/0003-4819-107-1-54
PMID:3592449
Abstract

Although the commonest familial form of primary hyperparathyroidism is parathyroid hyperplasia, a few families have manifested parathyroid adenomas. We describe a family in which four members developed cystic parathyroid adenomas. Although calcium levels returned to normal after resection of the adenoma, a second adenoma would often develop several years later (we have termed this temporal sequence adenomatosis). Each adenoma had a cystic histologic appearance, and three of four normal-sized parathyroid glands also contained many cysts. No other endocrine tumors have appeared, but in three patients the hyperparathyroidism was complicated by fibrous maxillary or mandibular tumors that resembled ossifying fibromas rather than the brown tumors generally found in patients with hyperparathyroidism. Each patient with an adenoma was hypercalciuric, but two were obligate carriers of hypocalciuric hypercalcemia. This familial occurrence of the rare cystic parathyroid adenoma suggests the presence of a distinct hereditary syndrome. The genetic basis may be the simultaneous inheritance of familial hypocalciuric hypercalcemia and another trait that may increase the urinary excretion of calcium.

摘要

虽然原发性甲状旁腺功能亢进最常见的家族形式是甲状旁腺增生,但少数家族表现为甲状旁腺腺瘤。我们描述了一个家族,其中四名成员患了囊性甲状旁腺腺瘤。虽然腺瘤切除后钙水平恢复正常,但几年后通常会出现第二个腺瘤(我们将这种时间顺序称为腺瘤病)。每个腺瘤都有囊性组织学表现,四个正常大小的甲状旁腺中有三个也含有许多囊肿。未出现其他内分泌肿瘤,但三名患者的甲状旁腺功能亢进并发了纤维性上颌或下颌肿瘤,这些肿瘤类似骨化性纤维瘤,而非甲状旁腺功能亢进患者中常见的棕色瘤。每个患有腺瘤的患者都有高钙尿症,但有两名是低钙尿性高钙血症的携带者。这种罕见的囊性甲状旁腺腺瘤的家族性发生提示存在一种独特的遗传综合征。其遗传基础可能是家族性低钙尿性高钙血症与另一种可能增加尿钙排泄的性状的同时遗传。

相似文献

1
Familial cystic parathyroid adenomatosis.家族性囊性甲状旁腺腺瘤病
Ann Intern Med. 1987 Jul;107(1):54-60. doi: 10.7326/0003-4819-107-1-54.
2
Tumor suppressor gene mutation in a patient with a history of hyperparathyroidism-jaw tumor syndrome and healed generalized osteitis fibrosa cystica: a case report and genetic pathophysiology review.一名有甲状旁腺功能亢进-颌骨肿瘤综合征病史且已治愈的全身性骨纤维囊性骨炎患者的肿瘤抑制基因突变:病例报告及遗传病理生理学综述
J Oral Maxillofac Surg. 2015 Jan;73(1):194.e1-9. doi: 10.1016/j.joms.2014.09.008. Epub 2014 Sep 28.
3
Parathyroid glands in familial benign hypercalcemia (familial hypocalciuric hypercalcemia).家族性良性高钙血症(家族性低钙尿性高钙血症)中的甲状旁腺
Am J Med. 1984 Jun;76(6):1021-6. doi: 10.1016/0002-9343(84)90852-0.
4
Familial isolated hyperparathyroidism due to multiple adenomas associated with ossifying jaw fibroma and multiple uterine adenomyomatous polyps.因多发腺瘤导致的家族性孤立性甲状旁腺功能亢进,与骨化性颌骨纤维瘤和多发性子宫腺肌病性息肉相关。
Eur J Endocrinol. 1998 May;138(5):557-61. doi: 10.1530/eje.0.1380557.
5
Molecular pathogenesis of parathyroid tumours.甲状旁腺肿瘤的分子发病机制。
Best Pract Res Clin Endocrinol Metab. 2018 Dec;32(6):891-908. doi: 10.1016/j.beem.2018.11.001. Epub 2018 Nov 20.
6
Association of parathyroid adenoma and familial hypocalciuric hypercalcaemia in a teenager.一名青少年甲状旁腺腺瘤与家族性低钙血症性高钙血症的关联。
Eur J Endocrinol. 2009 Jul;161(1):207-10. doi: 10.1530/EJE-09-0257. Epub 2009 May 7.
7
Familial hyperparathyroidism: report of a case.家族性甲状旁腺功能亢进症:一例报告
Surg Today. 1999;29(1):63-6. doi: 10.1007/BF02482972.
8
Familial primary hyperparathyroidism complicated with Wilms' tumor.家族性原发性甲状旁腺功能亢进症合并肾母细胞瘤。
Intern Med. 1994 Feb;33(2):123-6. doi: 10.2169/internalmedicine.33.123.
9
Molecular pathogenesis of primary hyperparathyroidism.原发性甲状旁腺功能亢进症的分子发病机制。
J Bone Miner Res. 2002 Nov;17 Suppl 2:N30-6.
10
[Hereditary variants of primary hyperparathyroidism--MEN1, MEN2, HPT-JT, FHH, FIHPT].[原发性甲状旁腺功能亢进症的遗传性变异——多发性内分泌腺瘤1型、多发性内分泌腺瘤2型、甲状旁腺功能亢进-颌骨肿瘤综合征、家族性低尿钙性高钙血症、家族性孤立性甲状旁腺功能亢进症]
Dtsch Med Wochenschr. 2011 Sep;136(38):1889-94. doi: 10.1055/s-0031-1286358. Epub 2011 Sep 13.

引用本文的文献

1
c.1155-3A>G is a pathogenic variant that causes aberrant splicing, disrupted parafibromin expression, and hyperparathyroidism-jaw tumor syndrome.c.1155-3A>G是一种致病变异,可导致异常剪接、副纤维蛋白表达中断以及甲状旁腺功能亢进-颌骨肿瘤综合征。
JBMR Plus. 2024 Nov 19;9(1):ziae149. doi: 10.1093/jbmrpl/ziae149. eCollection 2025 Jan.
2
OVARIAN GRANULOSA CELL TUMOR IN A PATIENT WITH A PATHOGENIC VARIANT IN THE GENE (HYPERPARATHYROIDISM-JAW TUMOR SYNDROME).一名携带基因(甲状旁腺功能亢进-颌骨肿瘤综合征)致病性变异的患者发生卵巢颗粒细胞瘤。
AACE Clin Case Rep. 2019 Apr 25;5(3):e222-e225. doi: 10.4158/ACCR-2018-0555. eCollection 2019 May-Jun.
3
Clinical Features, Treatment, and Surveillance of Hyperparathyroidism-Jaw Tumor Syndrome: An Up-to-Date and Review of the Literature.
甲状旁腺功能亢进-颌骨肿瘤综合征的临床特征、治疗及监测:文献综述与最新进展
Int J Endocrinol. 2019 Dec 18;2019:1761030. doi: 10.1155/2019/1761030. eCollection 2019.
4
Evolution of Our Understanding of the Hyperparathyroid Syndromes: A Historical Perspective.我们对甲状旁腺功能亢进综合征认识的演变:历史视角。
J Bone Miner Res. 2019 Jan;34(1):22-37. doi: 10.1002/jbmr.3650. Epub 2018 Dec 10.
5
Parathyroid cysts: the Latin-American experience.甲状旁腺囊肿:拉丁美洲的经验
Gland Surg. 2016 Dec;5(6):559-564. doi: 10.21037/gs.2016.12.08.
6
Management of Ossifying Fibroma in a Suspicious Case of Hyperparathyroid-Jaw Tumor Syndrome.甲状旁腺机能亢进-颌骨肿瘤综合征疑似病例中骨化性纤维瘤的管理
Craniomaxillofac Trauma Reconstr. 2015 Sep;8(3):228-33. doi: 10.1055/s-0034-1395381. Epub 2014 Dec 2.
7
Two cases of multiple ossifying fibromas in the jaws.两例颌骨多发性骨化性纤维瘤。
Diagn Pathol. 2014 Mar 28;9:75. doi: 10.1186/1746-1596-9-75.
8
The EIF4EBP3 translational repressor is a marker of CDC73 tumor suppressor haploinsufficiency in a parathyroid cancer syndrome.EIF4EBP3 翻译抑制因子是甲状旁腺癌综合征中 CDC73 肿瘤抑制基因单倍体不足的一个标志物。
Cell Death Dis. 2012 Feb 2;3(2):266. doi: 10.1038/cddis.2012.6.
9
Parathyroid cancer.甲状旁腺癌。
Semin Oncol. 2010 Dec;37(6):580-90. doi: 10.1053/j.seminoncol.2010.10.013.
10
Cytoplasmic polyadenylation element binding protein is a conserved target of tumor suppressor HRPT2/CDC73.细胞质多聚腺苷酸化元件结合蛋白是肿瘤抑制因子 HRPT2/CDC73 的一个保守靶标。
Cell Death Differ. 2010 Oct;17(10):1551-65. doi: 10.1038/cdd.2010.32. Epub 2010 Mar 26.